genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Antibody Drug Conjugates
AbCellera’s CEO: Flattening the Curve of Technology Development
Cancer
After Final Medicare LCD from Palmetto GBA, OncoCyte Pursues Private Coverage…
Coronavirus
COVID-19 Puts Spotlight on Artificial Intelligence
Data Management
VAST Ambition When It Comes To Data Storage
Antisense
NeuBase Sets a Course for the Clinic
News
Cancer
AstraZeneca, Accent Launch up to $1.1B+ Cancer Collaboration Targeting RNA-Modifying Proteins
Cancer
Cancer Tumor Mutation Used as Potential Tracking Device for CRISPR Deployment
Gene Therapy
Base Editing Gene Therapy Restores Hearing in Mice
Antibacterials
Antibiotic Compound Kills Gram-Negative Pathogens and Resists Resistance
News
Identifying At-Risk Heart Attack Patients Not Found via Standard Evaluation
Insights
All
Trends for 2020
Bioprocessing
Reducing Risk and Illustrating Benefits Speed Innovation
Bioprocessing
Building Scale for Cell and Gene Therapy
Bioprocessing
COVID-19 Will Have Long Lasting Impact on Biopharma Manufacturing
Bioprocessing
Decreasing the Time from Antibody Idea to IND Approval
A-Lists
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
April 2020 Vol. 40 No.4
Catching Up to Coronavirus: Top 60 Treatments in Development
Drug Discovery
Top 15 Best-Selling Drugs of 2019
Coronavirus
How to Conquer Coronavirus: Top 35 Treatments in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Cancer
AstraZeneca, Accent Launch up to $1.1B+ Cancer Collaboration Targeting RNA-Modifying Proteins
Cancer
Cancer Tumor Mutation Used as Potential Tracking Device for CRISPR Deployment
Gene Therapy
Base Editing Gene Therapy Restores Hearing in Mice
Antibacterials
Antibiotic Compound Kills Gram-Negative Pathogens and Resists Resistance
Magazine
All
Supplement
Coronavirus
Race for a Coronavirus Vaccine
Drug Discovery
Protein Modulation Helps Drug Design Get a Grip
OMICs
Proteomic Mass Spec Assesses Biomolecular Teamwork
Coronavirus
COVID-19 Drives CRISPR Diagnostics
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
Kicking Up an Immune System Storm: COVID-19 and Hyper-Inflammation
Upcoming Webinars
Organoids and Spheroids Help Science See in 3D
Upcoming Webinars
A CRISPR Vision for the Future of Cell Therapy
Upcoming Webinars
Looking toward the Future of Cell & Gene Therapies
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Magazine
April 2020 Vol. 40 No.4
April 2020 Vol. 40 No.4
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
April 2020 Vol. 40 No.4
Artificial Intelligence Is Helping Biotech Get Real
April 2020 Vol. 40 No.4
Cell-Based Immunotherapies Do Battle With Solid Tumors
April 2020 Vol. 40 No.4
Cancer Drug Discovery’s “RASzle-Dazzle”
April 2020 Vol. 40 No.4
Coordinating the Move to Bioprocessing 4.0
April 2020 Vol. 40 No.4
Sequencing’s Stars Urge Exploration of New Dimensions
April 2020 Vol. 40 No.4
As Needs Change, the CRO Industry Adapts
April 2020 Vol. 40 No.4
Making the Most of a CDMO Relationship
April 2020 Vol. 40 No.4
Bioprocessing 4.0 from a Contract Manufacturing Perspective
April 2020 Vol. 40 No.4
AI Brings Precision to Cancer Immunotherapy
April 2020 Vol. 40 No.4
Immunotherapy Gets Up Close and Personal
April 2020 Vol. 40 No.4
Infiltrating Solid Tumor Strongholds
April 2020 Vol. 40 No.4
Microbiome May Join Immunotherapy-Boosting Efforts
April 2020 Vol. 40 No.4
Genetically Edited Cell Lines Enter the Fast Lane
April 2020 Vol. 40 No.4
A New Lease on Life for shRNA
April 2020 Vol. 40 No.4
To Improve Protein Aggregation Assessments, Combine PCT and MMS
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
